The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic Neuropathy

NCT06461377 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes
Diabetes With Diabetic Autonomic Neuropathy (Diagnosis)

Interventions

DRUG: Glucagon-like peptide-1 receptor agonist：Semaglutide

Sponsor

The First Affiliated Hospital with Nanjing Medical University